University of Texas Health Science Center at San Antonio: Data Analysis Shows Convalescent Plasma Improves Survival in COVID-19 Patients With Blood Cancers
February 12, 2021
February 12, 2021
SAN ANTONIO, Texas, Feb. 12 (TNSRes) -- The University of Texas Health Science Center at San Antonio issued the following news release:
Treatment with convalescent plasma was associated with significant survival benefit in patients with blood cancer who were hospitalized with COVID-19. The new data analysis was released Feb. 5 by the COVID-19 and Cancer Consortium (CCC19).
The Mays Cancer Center, home to UT Health San Antonio MD Anderson, is part of the CCC19. The inter . . .
Treatment with convalescent plasma was associated with significant survival benefit in patients with blood cancer who were hospitalized with COVID-19. The new data analysis was released Feb. 5 by the COVID-19 and Cancer Consortium (CCC19).
The Mays Cancer Center, home to UT Health San Antonio MD Anderson, is part of the CCC19. The inter . . .